The Importance of Patient-Centric Clinical Trials
Working to Improve Patient Access to Clinical Trials
Clinical trials are widely recognized as the best form of cancer care, providing access to the latest breakthroughs science can provide.
But only 2-8% of cancer patients gain access to these trials, due to a combination of factors. The COVID-19 pandemic has led to a revolution in how cancer trials are conducted, decentralizing them from major cities and academic medical institutions, and making them available to more diverse populations of cancer patients around the world. This model can help accelerate breakthroughs.
Cure4Cancer is talking to policymakers around the world to increase access to the latest treatments and to standardize the approval processes so that the whole world can benefit from the latest treatments. Add your voice by joining us on social media or writing a letter to your local representative.
